A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: endocrine and clinical results. The Italian Trials in Medical Oncology (I.T.M.O.) group. [electronic resource]
- Annals of oncology : official journal of the European Society for Medical Oncology Jul 1997
- 649-54 p. digital